billS4509•Event Wednesday, May 13, 2026Analyzed

PBM Act

Bearish

Summary

The PBM Act (S. 4509) prohibits common ownership of pharmacy benefit managers and pharmacies, directly targeting CVS Health, UnitedHealth Group, and Cigna. At an early legislative stage, near-term probability is low, but if enacted, would force major divestitures and reshape the healthcare supply chain.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.The PBM Act targets vertical integration of PBMs and pharmacies, with CVS and UnitedHealth most at risk.
  • 2.No funding is involved; it is a structural prohibition requiring divestiture.
  • 3.Early stage legislation with low near-term probability but significant long-term implications for the healthcare sector.

Market Implications

The PBM Act introduces a clear bearish catalyst for CVS and UnitedHealth, as their vertical integration is directly challenged. Without real market data, the focus should be on the legislative process: if the bill gains cosponsors or advances to markup, expect headline risk and potential valuation compression. For Cigna, the impact is smaller but still notable. In contrast, independent pharmacy chains like Walgreens ($WBA) may see relative outperformance if the bill reduces PBM steering to captive pharmacies, though this is peripheral.

Full Analysis

On May 13, 2026, Sen. Warren introduced the Patients Before Monopolies Act (PBM Act, S. 4509) to separate pharmacy benefit managers (PBMs) from pharmacies under common ownership. The bill was read twice and referred to the Senate Judiciary Committee. The legislation is in an early stage with no committee action yet. It does not authorize any spending—it is a structural prohibition, not a funding bill.

The primary targets are vertically integrated health conglomerates that own both a PBM and a large pharmacy network. CVS Health (Caremark PBM + CVS Pharmacy) is the most exposed, followed by UnitedHealth Group (Optum Rx PBM + Optum Pharmacy). Cigna (Express Scripts PBM + Evernorth specialty pharmacy) has moderate exposure. Independent pharmacies and chains without PBM ownership (e.g., Walgreens, Rite Aid) would face less direct impact and could benefit from reduced steering to affiliated pharmacies.

Market reaction has been muted given the early stage, but the bill adds legislative overhang. For retail investors, the key risk is a forced divestiture scenario: CVS and UNH would likely be required to spin off either their PBM or pharmacy assets, eliminating cross-selling synergies and potentially unlocking value in separate entities but creating near-term operational disruption. The legislative path requires committee markup, Senate floor vote, House passage, and presidential action—unlikely before the 2026 midterm elections. However, growing bipartisan scrutiny of PBMs (cosponsors include both Democrats and Republicans) suggests this issue has staying power.

Intelligence Surface

Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures

Unconfirmed

No confirming evidence found yet from contracts, insider trades, or congressional activity

$$CVS▼ Bearish
①

What the bill does

Prohibition on common ownership of PBM and pharmacy operations

②

Who must act

CVS Health (owns Caremark PBM and CVS Pharmacy retail chain)

③

What happens

Forced divestiture of either PBM or pharmacy assets, eliminating vertical integration synergies and market power

④

Stock impact

CVS derives ~70% of revenue from PBM (Caremark) and retail pharmacy; separation would dismantle cross-subsidization and potentially reduce profitability in both segments

$$UNH▼ Bearish
①

What the bill does

Prohibition on common ownership of PBM and pharmacy operations

②

Who must act

UnitedHealth Group (owns Optum Rx PBM and Optum Pharmacy, including mail-order and specialty pharmacies)

③

What happens

Forced divestiture of Optum Rx or Optum Pharmacy, severing vertically integrated pharmacy benefit and pharmacy services

④

Stock impact

Optum contributes ~40% of UNH's revenue; the PBM and pharmacy operations are key to Optum's value proposition; divestiture would reduce competitive advantage in managing drug costs

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

Exec OrderOct 19, 2026

Advancing Women's Health to Improve Outcomes in All Phases of Life

This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.

Exec OrderSep 18, 2026

Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program

This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.

proclamationSep 8, 2026

Accelerating Access To Veterans' Benefits And Employment Opportunities

This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →